Ibrutinib for Chronic Lymphocytic Leukemia User Reviews (Page 3)
Brand names: Imbruvica
Ibrutinib has an average rating of 6.8 out of 10 from a total of 52 reviews for the treatment of Chronic Lymphocytic Leukemia. 60% of reviewers reported a positive experience, while 29% reported a negative experience.
Reviews for Ibrutinib
- leste...
- Taken for 1 to 2 years
- January 4, 2018
"I have been taking imbruvica for 1 year. WBC count went from 44,000 to 10,000. Took a year but feeling great with no severe side effects whatsoever. I take 3 each morning. Amazing so far."
- Anne
- Taken for 2 to 5 years
- May 31, 2024
Imbruvica (ibrutinib) "Brought white blood cell count back to normal. On it for three years. Today I found out I now have atrial fibrillation!"
Frequently asked questions
- How long can you stay on Imbruvica (ibrutinib)?
- How much does Imbruvica cost?
- Can ibrutinib be stopped safely?
- Acalabrutinib vs. ibrutinib: How do they compare?
- Chas
- Taken for 6 months to 1 year
- March 29, 2024
Imbruvica (ibrutinib) "I have taken Imbruvica from May 2023 until this week when it was stopped due to a severe rash on my torso, head, and arms."
- Anonymous
- Taken for 5 to 10 years
- December 1, 2023
Imbruvica (ibrutinib) "Has kept me alive - I had recurring Hodgkin's Lymphoma 7 years or so ago. Has side effects though - bruising easily - eyesight changing - increased blood pressure and fatigue"
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Chronic Lymphocytic Leukemia
Care guides
Symptoms and treatments
More about ibrutinib
- Check interactions
- Compare alternatives
- Reviews (74)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: BTK inhibitors
- Breastfeeding
- En español
"Went thru Rituximab treatment first. Now taking for over the year.No side effects. My WC count dropped from 450,000 to 11.500. Feel very good"